These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33307199)
1. Two sides of the same coin: Insights into the myoepithelial cells in carcinoma ex pleomorphic adenoma development. Scarini JF; Egal ESA; de Lima-Souza RA; Crescencio LR; Emerick C; Kowalski LP; Altemani A; Mariano FV Crit Rev Oncol Hematol; 2021 Jan; 157():103195. PubMed ID: 33307199 [TBL] [Abstract][Full Text] [Related]
2. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma. de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265 [TBL] [Abstract][Full Text] [Related]
3. Carcinoma ex pleomorphic adenoma of minor salivary glands with major epithelial-myoepithelial component: clinicopathologic and immunohistochemical study of 3 cases. Sedassari BT; Dos Santos HT; Mariano FV; da Silva Lascane NA; Altemani A; Sousa S Ann Diagn Pathol; 2015 Jun; 19(3):164-8. PubMed ID: 25890488 [TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of the suppressor potential of conditioned medium from benign myoepithelial cells from pleomorphic adenoma in malignant cell invasion. da Silva AD; Silva CA; Montalli VA; Martinez EF; de Araújo VC; Furuse C J Oral Pathol Med; 2012 Sep; 41(8):610-4. PubMed ID: 22680065 [TBL] [Abstract][Full Text] [Related]
5. Carcinoma ex pleomorphic adenoma: A diagnostic challenge on cytology. Singh K; Agarwal C; Pujani M; Verma P; Chauhan V Diagn Cytopathol; 2017 Jul; 45(7):651-654. PubMed ID: 28261993 [TBL] [Abstract][Full Text] [Related]
6. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma. de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205 [TBL] [Abstract][Full Text] [Related]
7. Pleomorphic adenoma with bizarre myoepithelial cells: A diagnostic challenge on cytologic smear. Taweevisit M; Thorner PS Diagn Cytopathol; 2019 Dec; 47(12):1283-1286. PubMed ID: 31400260 [TBL] [Abstract][Full Text] [Related]
8. FGF-2 is overexpressed in myoepithelial cells of carcinoma ex-pleomorphic adenoma in situ structures. Martinez EF; Demasi AP; Miguita L; Altemani A; Araújo NS; Araújo VC Oncol Rep; 2010 Jul; 24(1):155-60. PubMed ID: 20514456 [TBL] [Abstract][Full Text] [Related]
9. Epithelial myoepithelial carcinoma of the parotid gland with malignant ductal and myoepithelial components arising in a pleomorphic adenoma: a case report with cytologic, histologic and immunohistochemical correlation. Daneshbod Y; Negahban S; Khademi B; Daneshbod K Acta Cytol; 2007; 51(5):807-13. PubMed ID: 17910353 [TBL] [Abstract][Full Text] [Related]
10. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome. Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747 [TBL] [Abstract][Full Text] [Related]
11. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899 [TBL] [Abstract][Full Text] [Related]
12. FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study. Miguita L; Martinez EF; de Araújo NS; de Araújo VC J Appl Oral Sci; 2010; 18(1):83-91. PubMed ID: 20379686 [TBL] [Abstract][Full Text] [Related]
13. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma. Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983 [TBL] [Abstract][Full Text] [Related]
14. Neural adhesion molecule (N-CAM) in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Saleh ER; França CM; Marques MM J Oral Pathol Med; 2003 Oct; 32(9):562-7. PubMed ID: 12969231 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Katabi N; Gomez D; Klimstra DS; Carlson DL; Lee N; Ghossein R Hum Pathol; 2010 Jul; 41(7):927-34. PubMed ID: 20338616 [TBL] [Abstract][Full Text] [Related]
16. [Histogenetic and morphogenetic problems of pleomorphic adenoma of the salivary glands]. Kraevskiĭ NA; Belous TA; Litvinova LV Arkh Patol; 1982; 44(4):9-18. PubMed ID: 6282240 [TBL] [Abstract][Full Text] [Related]
17. [Myoepithelial carcinoma ex-pleomorphic adenoma of the parotid gland]. Rammeh-Rommani S; Trabelsi A; Stita W; Mokni M; Jaidane L; Yakoubi MT; Moatemri R; Korbi S Rev Stomatol Chir Maxillofac; 2007 Nov; 108(5):465-7. PubMed ID: 17884120 [TBL] [Abstract][Full Text] [Related]
18. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation. Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915 [TBL] [Abstract][Full Text] [Related]